Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-08-2007 | Clinical Investigation

High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up

Authors: Dirk Sandner, Erdmuth Herbrig, Katrin Engelmann

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 8/2007

Abstract

Background

The high-density silicone oil (Densiron 68), a mixture of F₆H₈ with silicone oil, seems to be a therapeutic option, at least in selected patients with complex inferior retinal re-detachment, where standard procedures have already failed. In an interventional case series we used Densiron as a primary endotamponade.

Methods

Twelve eyes of 12 patients aged 31 years to 85 years with inferior complex rhegmatogenous retinal detachment with secondary proliferative vitreoretinopathy (PVR) grades CP2 to CA8 were included. Surgical techniques (pars plana vitrectomy, membrane peeling, retinotomy, retinectomy, endophotocoagulation, cryocoagulation, endotamponade) did not include a scleral buckling procedure (except one eye). Mean duration of the Densiron endotamponade was 78.3 ± 29.74 days, with a mean follow up after removal of 400.6 ± 85.4 days.

Results

After Densiron removal, four patients (33.3%) showed a stable reattached retina without further interventions, while, in six patients (50%), recurrent retinal re-detachment appeared during endotamponade, generally within 2 months. One patient (8.3%) developed re-detachment 5 months after Densiron removal. One eye (8.3%) lost light perception due to severe intraretinal fibrosis with chronic hypotonia, despite complete retinal re-attachment. Visual acuity improved from mean logarithm of the minimum angle of resolution (logMAR) of 2.95 ± 1.21 to 1.87 ± 1.32 (statistically significant, P = 0.022). Side effects included temporary inflammatory reaction/fibrin accumulation (n = 2/2), moderate-to-severe intraretinal fibrosis (n = 3), elevated intraocular pressure (IOP) (n = 3), emulsification (n = 2), sterile hypopyon (n = 1), vitreous haemorrhage (n = 1) and chronic hypotony (n = 1).

Conclusion

Primary anatomical success rate of 33.3% was less encouraging than as expected. Especially, re-detachments within the posterior staphyloma in highly myopic patients were common during Densiron endotamponade. However, the surgical success increased to 75% after re-intervention, even without the use of an additional encircling band. The observed adverse effects and the functional outcomes do not contraindicate the use of Densiron as an internal tamponade for a period of 3 months.

Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R (1991) Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 11:367–374PubMed

Chang S, Zimmerman NJ, Iwamoto T, Ortiz R, Faris D (1987) Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 103:29–37PubMed

Dresp JH, Menz D-H (2005) Interaction of different ocular endotamponades as a risk factor for silicone oil emulsification. Retina 25:902–910PubMedCrossRef

Falkner CI, Binder S, Kruger A (2001) Outcome after silicone oil removal. Br J Ophthalmol 85:1324–1327PubMedCrossRef

Fisk MJ, Cairns JD (1995) Silicone oil insertion. A review of 127 consecutive cases. Aust N Z J Ophthalmol 23:25–32PubMed

Flaxel CJ, Mitchell SM, Aylward GW (2000) Visual outcome after silicone oil removal and recurrent retinal detachment repair. Eye 14:834–838PubMed

Gabel VP, Kampik A, Gabel C, Spiegel D (1987) Silicone oil with high specific gravity for intraocular use. Br J Ophthalmol 71:262–267PubMed

Gerding H, Kolck A (2004) [Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months]. Ophthalmologe 101:255–262PubMedCrossRef

Gremillion CM Jr, Peyman GA, Liu KR, Naguib KS (1990) Fluorosilicone oil in the treatment of retinal detachment. Br J Ophthalmol 74:643–646PubMed

10.

Hiscott P, Magee RM, Colthurst M, Lois N, Wong D (2001) Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol 85:179–183PubMedCrossRef

11.

Hoerauf H, Kobuch K, Dresp J, Menz DH (2001) Combined use of partially fluorinated alkanes, perfluorocarbon liquids and silicone oil: an experimental study. Graefes Arch Clin Exp Ophthalmol 239:373–381PubMed

12.

Jonas JB, Knorr HL, Rank RM, Budde WM (2001) Retinal redetachment after removal of intraocular silicone oil tamponade. Br J Ophthalmol 85:1203–1207PubMedCrossRef

13.

Kampik A, Hoing C, Heidenkummer HP (1992) Problems and timing in the removal of silicone oil. Retina 12:S11–S16PubMedCrossRef

14.

Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N, Schrage NF (2002) Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 133:95–101PubMedCrossRef

15.

Kobuch K, Menz IH, Hoerauf H, Dresp JH, Gabel VP (2001) New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 239:635–642PubMed

16.

La Heij EC, Hendrikse F, Kessels AG (2001) Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments. Retina 21:107–114PubMedCrossRef

17.

Lucke K, Laqua H (1990) Proliferative vitreoretinopathy silicone oil in the treatment of complicated retinal detachments. Springer, Berlin Heidelberg New York, pp 81–88

18.

Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112:159–165PubMed

19.

Malchiodi-Albedi F, Matteucci A, Formisano G, Paradisi S, Carnovale-Scalzo G, Perilli R, Scorcia G, Caiazza S (2003) Perfluorohexyloctane (F6H8) induces structural modifications and increases apoptosis in rat primary retinal cultures. J Biomed Mater Res B Appl Biomater 65:133–136PubMedCrossRef

20.

Meinert H, Roy T (2000) Semifluorinated alkanes—a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 10:189–197PubMed

21.

Mertens S, Bednarz J, Engelmann K (2002) Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types. Graefes Arch Clin Exp Ophthalmol 240:989–995

22.

Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM (1984) Perfluoroether liquid as a long-term vitreous substitute. An experimental study. Retina 4:264–268PubMedCrossRef

23.

Nabih M, Peyman GA, Clark LC Jr, Hoffman RE, Miceli M, Abou-Steit M, Tawakol M, Liu KR (1989) Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: a preliminary report. Ophthalmic Surg 20:286–293PubMed

24.

Pastor JC, Mendez MC, de la Fuente MA, Coco RM, Garcia-Arumi J, Rodriguez de la Rua E, Fernandez N, Saornil MA, Gayoso MJ (2006) Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening. Ophthalmic Res 38:193–200PubMedCrossRef

25.

Roider J, Hoerauf H, Kobuch K, Gabel VP (2002) Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 240:965–971PubMed

26.

Sandner D, Engelmann K (2006) First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment Graefes Arch Clin Exp Ophthalmol 244:609–619PubMedCrossRef

27.

Schatz B, El-Shabrawi Y, Haas A, Langmann G (2004) Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgery. Retina 24:567–573PubMedCrossRef

28.

Schatz B, Langmann G, Faulborn J (2001) Erfahrungen mit Fluoron (F6H8) als Tamponade in der komplexen Netzhautchirurgie. Spektrum Augenheilkd 15:238–241CrossRef

29.

Scott IU, Flynn HW, Lai M, et al (2000) First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am J Ophthalmol 130:745–750PubMedCrossRef

30.

Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG (2005) Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 46:329–342PubMedCrossRef

31.

Sharma T, Gopal L, Shanmugam MP, et al (2002) Management of recurrent retinal detachment in silicone oil-filled eyes. Retina 22:153–157PubMedCrossRef

32.

Sparrow JR, Matthews GP, Iwamoto T, Ross R, Gershbein A, Chang S (1993) Retinal tolerance to intravitreal perfluoroethylcyclohexane liquid in the rabbit. Retina 13:56–62PubMedCrossRef

33.

Stolba U, Krepler K, Pflug R, Velikay M, Wedrich A, Binder S (1997) Experimental vitreous and aqueous replacement with perfluorophenanthrene. Clinical, histologic, and electrophysiologic results. Retina 17:146–153PubMedCrossRef

34.

Stolba U, Krepler K, Velikay-Parel M, Binder S (2004) The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol 242:931–936PubMedCrossRef

35.

Theelen T, Tilanus M, Klevering BJ (2004) Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol 242:617–620PubMed

36.

Tognetto D, Minutola D, Sanguinetti G, Ravalico G (2005) Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study. Ophthalmology 112:1574–1578, SepPubMedCrossRef

37.

Velikay M, Wedrich A, Stolba U, Datlinger P, Li Y, Binder S (1993) Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin. Am J Ophthalmol 116:565–570PubMed

38.

Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A (2003) Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Exp Ophthalmol 31:408–414CrossRef

39.

Wolf S, Schon V, Meier P, Wiedemann P (2003) Silicone oil-RMN3 mixture (“heavy silicone oil”) as internal tamponade for complicated retinal detachment. Retina 23:335–342PubMedCrossRef

40.

Wong D, Van Meurs JC, et al (2005) A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 89:662–665PubMedCrossRef

41.

Wong D, Williams R, Stappler T, Groenewald C (2005) What pressure is exerted on the retina by heavy tamponade agents? Graefes Arch Clin Exp Ophthalmol 243:474–477PubMedCrossRef

42.

Yamamoto S, Takeuchi S (2000) Silicone oil and fluorosilicone. Semin Ophthalmol 15:15–24PubMedCrossRef

43.

Zeana D, Becker J, Kuckelkorn R, Kirchhof B (1999) Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 23:17–24PubMedCrossRef

Title: High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up
Authors: Dirk Sandner
Erdmuth Herbrig
Katrin Engelmann
Publication date: 01-08-2007
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2007
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-006-0496-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2007

Surgical induction of choroidal neovascularization in a porcine model

Assessment of macular function by multifocal electroretinography following epiretinal membrane surgery with indocyanine green-assisted internal limiting membrane peeling

Structural alterations of the erythrocyte membrane proteins in diabetic retinopathy

Alterations of amino acids and glutamate transport in the DBA/2J mouse retina; possible clues to degeneration

Assessment of macular function by multifocal electroretinography following epiretinal membrane surgery with indocyanine green-assisted internal limited membrane peeling: reply

Successful treatment of a large choroidal abscess in an immunocompetent child